PF-06821497 (b)

CAS No. 1844849-11-1

PF-06821497 (b)( PF06821497 )

Catalog No. M12850 CAS No. 1844849-11-1

PF-06821497 (PF06821497) is a novel potent, selective, orally bioavailable EZH2 inhibitor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PF-06821497 (b)
  • Note
    Research use only, not for human use.
  • Brief Description
    PF-06821497 (PF06821497) is a novel potent, selective, orally bioavailable EZH2 inhibitor.
  • Description
    PF-06821497 (PF06821497) is a novel potent, selective, orally bioavailable EZH2 inhibitor with Ki of <0.1 and 1.15 nM aginast both wt and mutant Y641N EZH2, respectively; weakly inhibits EZH1 (Ki=70 nM) and no significant affinity against a panel of other HMTases; inhibits Karpas-422 cell proliferation with IC50 of 23 nM, cell H3K27me3 IC50 of 17 nM; shows robust tumor growth inhibition in vivo.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    PF06821497
  • Pathway
    Chromatin/Epigenetic
  • Target
    HMTase
  • Recptor
    HMTase
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1844849-11-1
  • Formula Weight
    467.343
  • Molecular Formula
    C22H24Cl2N2O5
  • Purity
    >98% (HPLC)
  • Solubility
    10 mM in DMSO
  • SMILES
    COC1=C(CN2CCC(C(Cl)=CC([C@@H](OC)C3COC3)=C4Cl)=C4C2=O)C(NC(C)=C1)=O
  • Chemical Name
    (S)-5,8-dichloro-7-(methoxy(oxetan-3-yl)methyl)-2-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3,4-dihydroisoquinolin-1(2H)-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Kung PP, et al.J Med Chem. 2017 Dec 6. doi: 10.1021/acs.jmedchem.7b01375.
molnova catalog
related products
  • EZH2-IN-3

    EZH2-IN-3 is a highly selective small molecule inhibitor of EZH2 and EZH1.

  • MAK683

    MAK683 (MAK-683) is a novel inhibitor of embryonic ectoderm development protein (EED) and allosteric inhibitor of polycomb repressive complex 2 (PRC2).

  • MS-453

    A potent, selective. covalent protein lysine methyltransferase SETD8 inhibitor with IC50 of 804 nM.